Aberrant cell-cycle activity and DNA damage are emerging as important pathological components in various neurodegenerative conditions. However, their underlying mechanisms are poorly understood. Here, we show that deregulation of histone deacetylase 1 (HDAC1) activity by p25/Cdk5 induces aberrant cell-cycle activity and double-strand DNA breaks leading to neurotoxicity. In a transgenic model for neurodegeneration, p25/Cdk5 activity elicited cellcycle activity and double-strand DNA breaks that preceded neuronal death. Inhibition of HDAC1 activity by p25/Cdk5 was identified as an underlying mechanism for these events, and HDAC1 gain of function provided potent protection against DNA damage and neurotoxicity in cultured neurons and an in vivo model for ischemia. Our findings outline a pathological signaling pathway illustrating the importance of maintaining HDAC1 activity in the adult neuron. This pathway constitutes a molecular link between aberrant cell-cycle activity and DNA damage and is a potential target for therapeutics against diseases and conditions involving neuronal death.
INTRODUCTION
In a variety of conditions involving neuronal death such as ischemia and Alzheimer's disease (Hayashi et al., 2000; Rashidian et al., 2007; Vincent et al., 1996; Yang et al., 2001) , neurons engage in aberrant cell-cycle activities, expressing cell-cycle markers such as Ki-67 and proliferating cell nuclear antigen (PCNA) and synthesizing DNA ). This is remarkable considering that neurons are terminally differentiated and remain quiescent for decades prior to the onset of these events. While the underlying mechanisms are poorly understood, these activities may play an early and contributory role in neuronal death (Busser et al., 1998; Herrup and Busser, 1995) . For example, overexpression of cell-cycle activity-inducing proteins such as SV40 large T antigen, c-Myc, c-Myb, or E2F1 can cause neuronal death in vitro and in vivo (al-Ubaidi et al., 1992; Konishi and Bonni, 2003; Liu and Greene, 2001) , while pharmacological inhibitors of cyclin-dependent kinases (CDKs) or other cell-cycle components can exert neuroprotective effects (Padmanabhan et al., 1999) .
DNA damage may also be involved in numerous conditions involving neuronal death (Adamec et al., 1999; Ferrante et al., 1997; Hayashi et al., 1999; Kruman et al., 2004; Robison and Bradley, 1984) . For example, oxidative damage to neuronal DNA is observed in rodent models of ischemia (Hayashi et al., 1999) . Accumulation of reactive oxygen species results in DNA damage, cell-cycle activity, and neurodegeneration in mutant mice with disrupted apoptosis-inducing factor (AIF) (Klein et al., 2002) . In addition, congenital syndromes with DNA repair gene mutations, such as ataxia telangiectasia and Werner's syndrome, display a progressive neurodegeneration phenotype, demonstrating the importance of maintaining DNA integrity in the adult brain (Rolig and McKinnon, 2000) . DNA damage is involved in the aging of the human brain (Lu et al., 2004) , which suggests that DNA damage may play a role in age-dependent neurodegenerative diseases as well.
Regulating histone acetylation is an integral aspect of chromatin modulation and gene regulation that plays a critical role in many biological processes including cell proliferation and differentiation (Roth et al., 2001) . Recent reports have detailed the importance of histone acetylation in central nervous system (CNS) functions such as neuronal differentiation, memory formation, drug addiction, and depression (Citrome, 2003; Tsankova et al., 2006) . Histone deacetylases (HDACs) remove acetyl groups from histones, resulting in chromatin compaction and decreased accessibility to DNA for interacting molecules such as transcription factors (Cerna et al., 2006) . Of these, histone deacetylase 1 (HDAC1) was the first mammalian protein identified to have histone-directed deacetylase activity (Taunton et al., 1996) . HDAC1 plays important roles in regulating the cell cycle and is required in the transcriptional repression of cell-cycle genes such as p21/WAF, E2F1, and cyclins A and E (Brehm et al., 1998; Lagger et al., 2002; Rayman et al., 2002; Stiegler et al., 1998) . The association of HDAC1 with promoter regions of specific genes is linked to their transcriptional repression (Brehm et al., 1998; Gui et al., 2004; Rayman et al., 2002) .
The serine/threonine kinase Cdk5 and its activating subunit p35 play important roles in both the developing and adult CNS (Dhavan and Tsai, 2001) . In numerous neurodegenerative states including postmortem Alzheimer's disease (AD) brains and animal models for stroke/ischemia (Lee et al., 2000; Nguyen et al., 2001; Patrick et al., 1999; Smith et al., 2003; Swatton et al., 2004; Wang et al., 2003) , neurotoxic stimuli induce calpainmediated cleavage of p35 into p25, the accumulation of which elicits neurotoxicity in cultured neurons and in vivo (Lee et al., 2000; Patrick et al., 1999) .
We have previously generated a bitransgenic mouse model (CK-p25 mice) that expresses a p25-GFP fusion protein under the control of the calmodulin kinase II (CaMKII) promoter in an inducible, postdevelopmental, and forebrain-specific manner (Cruz et al., 2003) . Upon induction of p25, neurodegenerative events occur in a rapid and orderly manner, as astrogliosis is observed after 4 weeks of induction, and neuronal loss and cognitive impairment are appreciable after 6 weeks of induction (Cruz et al., 2003; Fischer et al., 2005) . Thus, this model may provide a tractable system for investigating mechanisms for neuronal death relevant to conditions involving p25, such as stroke/ ischemia.
Here, we examined the gene expression profile in p25 transgenic mice induced for a short period to gain insights into early and instigating mechanisms involved in neurodegeneration. We observed that following p25 induction, neurons aberrantly express cell-cycle proteins and form double-strand DNA breaks at an early stage prior to their death. p25 interacted with and inactivated HDAC1, and inactivation of HDAC1 through siRNA knockdown or pharmacological inhibition resulted in doublestrand DNA breaks, aberrant cell-cycle protein expression, and neuronal death. Importantly, restoring HDAC1 activity by overexpressing wild-type HDAC1, but not the deacetylase activitydeficient mutant, rescued against p25-mediated double-strand DNA breaks and cell death. Furthermore, we provide evidence that this pathway is relevant in an in vivo model for stroke. Our findings suggest that the inactivation of HDAC1 by p25 may be involved in the pathogenesis of neurodegenerative diseases.
RESULTS

Gene Expression Profile of CK-p25 Transgenic Mice
In CK-p25 mice induced for 2 weeks, widespread forebrain neuron-specific expression of p25-GFP is observed (see Figure S1 available online) without signs of neurotoxicity or reactive astrogliosis (Fischer et al., 2005) . We carried out microarray analyses of CK-p25 mouse forebrains (Affymetrix; see Supplemental Experimental Procedures) at this period of induction in hopes of elucidating the initiating mechanisms accounting for the neurodegeneration observed in later weeks. A total of 225 genes (292 total probes) were found to be significantly altered in the induced transgenics compared to uninduced controls (Table S1 ). Surprisingly, genes involved in cell-cycle or DNA damage repair/ response (Gene Ontology database, http://www.geneontology. org/) were highly represented (Table S2) , totaling 65 genes (84 total probes) with overlap between the annotation groups. Representative genes from these groups are summarized in Table 1 . Of the 65 genes, 63 were upregulated, including cell-cycle/proliferation genes such as cyclins A, B, and E, E2F1, , and PCNA, which have previously been shown to be upregulated in postmortem AD brains and rodent stroke models. In addition, a number of DNA damage response genes, in particular genes involved in the double-strand DNA break response such as Rad51, BRCA1, and checkpoint 1 (Chk1), were found to be highly upregulated. Collectively, these findings suggest the aberrant expression of cell-cycle proteins and a response to double-strand DNA breaks in the brains of CK-p25 mice.
p25 Induction Results in Aberrant Expression of Cell-Cycle Proteins
We examined the expression of various cell-cycle proteins in CK-p25 mouse brains to confirm their aberrant upregulation as suggested by the microarray analyses. We confirmed by semiquantitative RT-PCR that mRNA levels of various cell-cycle genes identified in the microarray were upregulated in CK-p25 mouse hippocampi compared to wild-type (WT) controls (Figure 1A) . In addition, protein levels of PCNA, E2F1, and cyclin A were upregulated compared to WT controls ( Figure 1B ). There was no change in levels of glial fibrillary acidic protein (GFAP), consistent with the absence of neurodegeneration at this period of induction. Immunostaining demonstrated robust increases in immunoreactivity for the cell-cycle progression/proliferation markers Ki-67 and PCNA in p25-expressing adult neurons, which were identified by the GFP signal ( Figures 1C and 1D) . Importantly, only neurons expressing p25-GFP were found to have increased levels of cell-cycle markers, while no neurons expressed these markers in WT mice. Some nonneuronal cells stained positively for these cell-cycle markers (e.g., in the subventricular zone) in both CK-p25 and WT brains (data not shown), reflecting normal cell-cycle activity in nonpostmitotic cells. In addition, a subset of p25-GFP neurons incorporated bromodeoxyuridine (BrdU), indicating DNA synthesis activity (data not shown). On the other hand, p25-GFP-expressing neurons were not immunoreactive for the mitotic marker phosphoserine 10 histone H3, indicating the absence of mitotic cell-cycle activity ( Figure 1E ). Our results imply that p25 induction results in aberrant expression of cell-cycle proteins in neurons and aberrant cell-cycle activity.
p25 Induction Results in Double-Strand DNA Breaks The microarray analyses also suggested that p25 expression induced many genes involved in the double-strand DNA break response. To determine whether double-strand DNA breaks occur in CK-p25 mice, brains from 2-week-induced mice were examined using the double-strand break marker phosphoserine 129 histone H2AX (gH2AX). Robust gH2AX immunoreactivity was detected both biochemically ( Figure 2A ) and by staining, revealing that gH2AX immunoreactivity was specific to p25-GFP-expressing neurons ( Figure 2B ). gH2AX staining was undetectable in WT brain neurons. The double-strand DNA break response protein Rad51 was also found to be upregulated in CK-p25 brains ( Figure 2A) .
We examined whether p25-mediated induction of doublestrand breaks could be recapitulated in cultured primary neurons using herpes simplex virus (HSV)-mediated overexpression of p25. Expression of p25 in primary neurons also resulted in robust generation of gH2AX ( Figures 2C and 2D ). To provide physical proof of DNA damage, primary neurons overexpressing p25 were analyzed for DNA strand breaks using single-cell gel electrophoresis (comet assay). We observed that nuclei of p25-overexpressing neurons displayed an 1.8-fold higher incidence of comet tails indicative of DNA containing single-or double-strand breaks ( Figure 2E ). These results demonstrate that expression of p25 induces DNA strand breaks in neurons. Microarray analysis was carried out as described in Experimental Procedures, and genes were organized into functional groups based on gene ontology. Genes with multiple gene ontology annotations (e.g., PCNA) were arbitrary placed into one of the groups. Fold change is measured in terms of expression levels for p25 compared to controls at 2 weeks of induction. The entire list of genes with significantly altered expression (Table S1 ) and cell-cycle/DNA damage-related genes (Table S2 ) are shown in the Supplemental Data.
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Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity Double-Strand DNA Damage and Cell-Cycle Activity Are Tightly Associated and Precede Neuronal Death Costaining with gH2AX and Ki-67 in CK-p25 mice revealed that neurons undergoing aberrant expression of cell-cycle proteins also exhibited double-strand DNA breaks, and vice versa, at high concurrency (92.3% ± 2.7% SD), suggesting that the two events are tightly linked ( Figure 3A ). In CK-p25 mice induced for 8 weeks (a period when massive neurodegeneration is evident [Cruz et al., 2003] ), the DNA damage marker gH2AX and the cell-cycle progression marker Ki-67 were each associated with pyknotic nuclei ( Figure 3B ). Over 70% of CA1 neurons in CK-p25 mice that were positive for both p25-GFP and gH2AX or both p25-GFP and Ki-67 had pyknotic nuclei, compared to only 34% of neurons positive for p25-GFP alone ( Figure 3B ). Experiments in cultured neurons ( Figure S2 ) and in vivo (Cruz et al., 2003) indicate that p25-expressing neurons die primarily through apoptosis as indicated by immunoreactivity to cleaved caspase-3 and cleaved PARP1. Interestingly, in CK-p25 mice subjected to p25 expression for 2 weeks followed by suppression of p25 expression for 4 weeks (by feeding a doxycycline diet), we observed that gH2AX signal was abrogated ( Figure 3C ), while no signs of neuronal loss were observed (Fischer et al., 2005) . This indicates that the degree of gH2AX formation observed after 2 weeks is reversible, and that gH2AX formation in CK-p25 mice precedes and is not secondary to cell death. Furthermore, we observed that the pan-caspase inhibitor z-VAD-fmk had no effect on p25-mediated gH2AX formation, further excluding DNA damage as a downstream consequence of apoptotic events ( Figure S3 ). (A) Hippocampi from 2-week-induced CK-p25 mice and wild-type (WT) mice were subjected to total RNA extraction, reverse transcription, and semiquantitative PCR analysis as described. Representative blots of mRNA levels of various cell-cycle genes from CK-p25 and WT hippocampi at 20, 25, and 30 cycles of semiquantitative RT-PCR are shown at left. Quantifications from multiple animals are displayed in the histogram at right. Band quantifications were normalized to actin levels. Data are displayed as average ± SEM fold increase over WT, with WT samples set to 1. p values (*p < 0.05) were calculated from multiple animals by two-tailed, unpaired Student's t test. (B) Forebrains from 2-week-induced CK-p25 mice and WT controls were analyzed for PCNA, cyclin A, and E2F1 protein levels. Glial fibrillary acidic protein (GFAP) and bIII-tubulin, used as loading control, were unchanged. (C) Ki-67, a cell-cycle progression marker, was upregulated in p25-expressing neurons in CK-p25 brains (top panels), but not in neurons of WT controls (bottom panels). The CA1 region is shown.
(D) Proliferating cell nuclear antigen (PCNA), a proliferation/S phase marker, is induced in p25-expressing neurons in CK-p25 brains (top panels), but not in neurons of WT controls (bottom panels). The CA1 region is shown.
(E) p25-expressing neurons in CK-p25 brains are not immunoreactive for the mitotic marker phosphoserine 10 histone H3 (pH3) (top panels). Subventricular zone (SVZ) of the same CK-p25 brain is shown as a positive control for mitotic cells that display phosphohistone H3 immunoreactivity. Scale bars = 50 mm.
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Collectively, our results demonstrate that cell-cycle and DNA damage events are tightly correlated with each other, and that they precede cell death in neurons with p25 accumulation.
p25 Interacts with and Inhibits HDAC1
The tight association of cell-cycle protein expression and DNA damage in CK-p25 mice suggested that a common mechanism might underlie these events. As both gene transcription and susceptibility to DNA damage are known to be tightly linked to the chromatin state, we considered the involvement of HDACs in the induction of aberrant neuronal cell-cycle expression and DNA damage by p25/Cdk5. Inhibition of HDACs can induce gene transcription and also increase sensitivity of DNA to DNA-damaging agents, both through increased accessibility (Cerna et al., 2006) .
Of particular interest was HDAC1, based on its reported role in transcriptional repression of cell-cycle-related genes such as p21/WAF, cyclins A, D, and E, and cdc25A (Brehm et al., 1998; Lagger et al., 2002; Stiegler et al., 1998) . We determined that in forebrains of CK-p25 mice induced for 2 weeks, p25 interacted with HDAC1 in vivo ( Figure 4A ). Interaction with HDAC1 was observed with both p25 and p35 cotransfected in 293T cells ( Figure 4B ). Interestingly, HDAC1 had a >12-fold higher degree of interaction with p25 compared to the physiological, noncleaved p35 ( Figure 4B ), which does not exert neurotoxicity. The preferential binding of HDAC1 with the pathological molecule p25 raised the interesting possibility that the p25/HDAC1 interaction may have deleterious consequences.
Because HDAC1 is exclusively localized in the nucleus (de Ruijter et al., 2003) , we examined the localization of p25-GFP in the CK-p25 mouse ( Figure S4 ). While abundant p25-GFP signal was observed in the cytoplasm, a lower but significant nuclear pool of p25-GFP was also observed, providing a basis for p25/HDAC1 interaction. This is consistent with previous reports of nuclear localization of p35 or p25 (O'Hare et al., 2005) .
We further characterized the p25/HDAC1 interaction by identifying the interaction domains. To this end, we generated multiple HDAC1 fragments spanning the entire protein, the C-terminal region, the N-terminal region containing the catalytic domain, or a small N-terminal region within the catalytic domain. By examining the ability of these fragments to coimmunoprecipitate with full-length p25, we mapped the interaction domain of p25 and 
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Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity HDAC1 to an N-terminal region within the histone deacetylase catalytic domain ( Figure 4C ).
The interaction of p25 with the catalytic domain of HDAC1 suggested that p25/Cdk5 may affect the enzymatic activity and/ or the function of HDAC1. Indeed, overexpression of p25 and Cdk5 in 293T cells resulted in a significant decrease in endogenous HDAC1 activity ( Figure 4D ). Importantly, inhibitory effects on endogenous HDAC1 activity were confirmed in vivo in hippocampi from 2-week-induced CK-p25 mice compared to WT controls ( Figure 4D ). Similar effects on HDAC1 activity were observed in primary neurons infected with p25-HSV (data not shown). To determine whether this was linked to increased HDAC1 repressor activity, we coexpressed p25 and Cdk5 with HDAC1-Gal4 in a luciferase reporter system. Fusion of HDAC1 with Gal4 significantly repressed Gal4 transcriptional activity (Nagy et al., 1997) ( Figure 4E , compare columns 2 and 1); however, coexpression with p25 increased HDAC1-Gal4-induced reporter activity 7.9-fold, indicating decreased repression by HDAC1 (column 3). Importantly, this effect was not observed with p35/Cdk5 or with p25/dominant-negative Cdk5 (columns 4 and 5), indicating that the inhibitory effect on HDAC1 transcriptional repression is specific to p25 and not p35 and that it requires Cdk5 activity.
Inhibition of HDAC catalytic activity results in the loss of HDAC1 association with the p21/WAF1 promoter region (Gui et al., 2004) . Therefore, we investigated whether p25/Cdk5 could inhibit the association of HDAC1 with the promoter of p21/WAF1 and other cell-cycle-related genes. First, we examined whether overexpression of p25 could affect the overall chromatin association of HDAC1 in primary neurons. We observed that HSV-mediated overexpression of p25 led to a decrease in chromatin-bound HDAC1 and an increase in the nucleoplasmic, non-chromatinbound fraction of HDAC1 ( Figure 4F ). Next, we carried out HDAC1 chromatin immunoprecipitation experiments in 293T cells transfected with p25/Cdk5 or a vector control to examine the association of HDAC1 with the core promoter regions of p21/WAF1 and E2F1. Overexpression of p25/Cdk5 resulted in a loss of HDAC1 association with p21/WAF1 and E2F1 promoters, as well as a concomitant increase in associated histone acetylation, suggesting a loss of histone deacetylation in this locus ( Figure 4G ). As HDAC1 association and local histone and gH2AX (red) carried out in 2-week-induced CK-p25 mice revealed that cell-cycle activity and double-strand DNA breaks occur concurrently. Representative images of the CA1 region are shown in the left panels, and quantification of neurons immunoreactive for both gH2AX and Ki-67, gH2AX only, or Ki-67 only from multiple 2-week-induced CK-p25 mice are shown in the histogram at right. a: gH2AX + Ki-67 versus gH2AX only, p < 0.001; b: gH2AX + Ki-67 versus Ki-67 only, p < 0.001. One-way ANOVA with Neuman-Keuls multiple comparison test was used to calculate p values. (B) gH2AX and Ki-67 are closely associated with dying neurons at 8 weeks of p25 induction. Representative images showing association of gH2AX and Ki-67 with pyknotic nuclei are shown in the first, second, and third panels. The fourth panel shows a magnification of the boxed region in third panel. Quantification of cell death (pyknotic nuclei) in p25-GFP-and gH2AX-immunoreactive neurons, p25-GFP-and Ki-67-immunoreactive neurons, and neurons immunoreactive for p25-GFP but not gH2AX or Ki-67 is shown from multiple 2-week-and 8-week-induced CK-p25 mice. a: p25 only versus p25 + gH2AX, p < 0.01; b: p25 only versus p25 + Ki-67, p < 0.01. One-way ANOVA with Neuman-Keuls multiple comparison test was used to calculate p values. Averages from multiple experiments ± SD are shown in (A) and (B). (C) CK-p25 mice were induced for 2 weeks (top panels) and sacrificed or were induced for 2 weeks followed by 4 weeks of suppression by doxycycline diet prior to sacrifice. Sections were examined for GFP and gH2AX signals. It was previously determined that 2 weeks of induction of p25 followed by 4 weeks of suppression does not result in neuronal loss (Fischer et al., 2005) . Scale bars = 100 mm.
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity deacetylation of specific promoter regions are linked with their repression, this result suggested that p25/Cdk5-mediated loss of HDAC1 activity and association with promoters of cell-cyclerelated genes may account for the aberrant expression of cellcycle-related genes observed in the CK-p25 mice.
Collectively, our results demonstrate that p25/Cdk5 inhibits multiple facets of HDAC1 function, including histone deacetylase activity, transcriptional repressor activity, and association with chromatin and specific promoter regions.
Inhibition of HDAC1 Induces DNA Damage, Cell-Cycle Activity, and Death Our findings raised the possibility that p25/Cdk5 might cause both cell-cycle activity and DNA damage through inhibition of A) Forebrains from 2-week-induced CK-p25 and WT control mice were homogenized, and lysates were immunoprecipitated with HDAC1 antibody as described and probed for p25-GFP and HDAC1. (B) FLAG-tagged HDAC1 was overexpressed with p25-GFP or p35-GFP in HEK293T cells, immunoprecipitated with FLAG-conjugated beads as described, and probed for p25-GFP or p35-GFP. (C) FLAG-tagged full-length HDAC1 or various truncation mutations were overexpressed with p25-GFP and immunoprecipitated with FLAG-conjugated beads as described. The catalytic domain is indicated in red-brown. (D) Left panel: HEK293T cells were transfected with vector or p25/Cdk5. Fifteen hours later, endogenous HDAC1 was immunoprecipitated and assayed for histone deacetylase activity as described. Averages from multiple experiments are displayed as fold change versus control (vector only). Right panel: hippocampi from 2-week-induced WT and CK-p25 mice were dissected and assayed for endogenous HDAC1 activity as described. p values (**p < 0.005, *p < 0.05) were calculated from multiple experiments by two-tailed, unpaired Student's t test. (E) p25/Cdk5 inhibits the transcriptional repressor activity of HDAC1. HDAC1-Gal4 construct was cotransfected with blank vector or p25/Cdk5 and then measured for luciferase reporter activity as described. Values were normalized to protein levels of Gal4 constructs and are expressed as relative light units (RLU) (HDAC1-Gal4 only = 1). (F) Primary cortical neurons were infected with GFP-HSV or p25-HSV and then subjected to fractionation as described. Lamin A and histone H3 were used as markers for the nuclear and chromatin fractions, respectively. Band densitometry quantifications are shown in the histogram on the right. Averages from multiple experiments ± SD are shown in (D)-(F) . (G) HEK293T cells were transfected with blank vector or p25 and Cdk5, crosslinked, and subjected to chromatin immunoprecipitation using HDAC1 or histone H3 acetylated at lysine 9 (aH3K9) antibody. Immunocomplexes were subjected to semiquantitative PCR amplification using primers toward the core promoter regions of E2F1 and p21/WAF.
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity HDAC1 activity. We examined the effects of siRNA-mediated knockdown and pharmacological inhibition of HDAC1. Knockdown of HDAC1 with a previously published sequence (see Supplemental Experimental Procedures) resulted in a significant increase in double-strand DNA breaks and cell death compared to the random sequence control ( Figure 5A ). In addition, treatment of primary neurons with a 1 mM concentration of the class I HDAC inhibitor MS-275, which results in >70% inhibition of HDAC1 activity with lesser effects on HDAC3 and HDAC8 (Hu et al., 2003) , was sufficient to increase double-strand DNA breaks (8.1-fold increase) and stimulate the aberrant expression of Ki-67 (1.8-fold increase) compared to controls ( Figure 5B ). These results demonstrate that inhibition of HDAC1 in neurons can induce double-strand DNA breaks and cell-cycle activity in neurons. (A and B) Primary cortical neurons were transfected with either HDAC1 siRNA or random sequence siRNA along with GFP at a 7:1 ratio to label transfected neurons. Cells were fixed at 24 hr, 48 hr, and 72 hr posttransfection and immunostained for gH2AX. GFP-positive neurons were scored for gH2AX immunoreactivity and for cell death based on nuclear condensation and neuritic integrity as described. (A) Left: representative micrographs. HDAC1 siRNA or control (random sequence) siRNA-transfected neurons are indicated by arrows. The HDAC1 siRNA-transfected neurons display neuritic breakage. The inset is a magnification of the gH2AX staining of the neuron indicated by the rightmost arrow in the lower left panel, showing gH2AX foci of varying sizes. Right: percentages of gH2AX and cell death. It was noted that transfection of control siRNA per se appeared to cause a low but significant baseline level of gH2AX immunoreactivity and cell death. (B) Primary cortical neurons were treated with a 1 mM concentration of the HDAC1 inhibitor MS-275 for 24 hr, fixed, and immunostained for gH2AX and Ki-67. Controls were treated with equal amounts of vehicle (DMSO). Total numbers of gH2AX-and Ki-67-positive neurons were quantified over 20 microscope fields (field diameter 900 mm). Averages from multiple experiments ± SD are shown in (A) and (B). (C) Wild-type mice were injected intraperitoneally with 50 mg/ kg MS-275 (n = 3) or saline (n = 3) daily for 10 days and then sacrificed and examined for gH2AX. MS-275 injection resulted in a dramatic induction of gH2AX within the CA1 (bottom panels), whereas saline injection did not induce gH2AX (top panels). Scale bars = 100 mm.
Furthermore, daily intraperitoneal injection of a high dose of MS-275 (50 mg/kg) for 10 days in WT mice resulted in a dramatic induction of gH2AX in CA1 neurons ( Figure 5C ) as well as other brain regions ( Figure S5 ), a result that was not observed with saline injection. In contrast to previous studies using the nonselective HDAC inhibitors sodium butyrate and trichostatin A Levenson et al., 2004) , MS-275 also impaired associative learning capability in WT mice in a dose-dependent manner, as assessed using a contextual fear conditioning paradigm ( Figure S6 ). These results support that loss of HDAC1 activity can cause DNA damage, neurodegeneration, and neurologic defects in vivo.
HDAC1 Gain of Function Rescues against DNA Damage and Neuronal Death in Cultured Neurons and In Vivo
Having demonstrated that inhibition of HDAC1 induces doublestrand DNA breaks and aberrant cell-cycle activity, we examined whether HDAC1 gain of function by overexpression can attenuate p25-mediated DNA damage and neurotoxicity. To this end, we overexpressed HDAC1 or control constructs followed by viral expression of p25 at a high rate of infection (>80%). Overexpression of HDAC1, but not HDAC2, decreased the percentage of neurons positive for p25-induced gH2AX by 37.9% compared Neuron Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity to GFP control ( Figure 6A ). We also examined whether coexpression of HDAC1 could rescue against cell death induced by transfection with p25-GFP. Coexpression of HDAC1, but not a catalytically dead mutant (HDAC1 H141A), rescued against p25-mediated neuronal death by 59.8% compared to the control ( Figure 6B ). Similar results were obtained when examining apoptosis as determined by cleaved caspase-3 immunoreactivity ( Figure S7 ). These results demonstrate that restoring HDAC1 activity can rescue against p25-mediated DNA damage and death.
Interestingly, treatment with the histone acetyltransferase (HAT) inhibitor garcinol also rescued against p25-mediated neurotoxicity ( Figure S7 ). However, coexpression of HDAC1 plus garcinol treatment did not have any additional protective benefit compared to HDAC1 coexpression or garcinol treatment alone ( Figure S7 ), suggesting that HDAC1 neuroprotection involves deacetylation of histones.
Next, we sought to examine whether the neuroprotective properties of HDAC1 could be recapitulated in an established in vivo model for stroke, i.e., rats subjected to transient forebrain ischemia. We and other groups have previously demonstrated the involvement of p25 in this model (Garcia-Bonilla et al., 2006; Wang et al., 2003; Wen et al., 2007) . Also, p25 is upregulated in human postmortem brains following ischemic stroke (Mitsios et al., 2007) . Furthermore, cell-cycle markers such as cyclin A, PCNA, and E2F1, which were upregulated in our p25 mice (Figure 1 ), are upregulated in rodent models for stroke/ischemia (Rashidian et al., 2007) .
Therefore, we examined whether gH2AX levels are upregulated in this model as well. Brains from rats subjected to unilateral transient forebrain ischemia for various periods were examined for gH2AX immunoreactivity. Increased gH2AX immunoreactivity was observed as early as 3 hr postischemia in the ischemic region ( Figure 6C ). Significant levels of gH2AX were not observed in the ipsilateral nonischemic region (data not shown) or the contralateral hemisphere ( Figure 6C ).
We examined whether overexpression of HDAC1 conferred neuroprotection in this model. To this end, Sprague-Dawley rats were injected with saline, blank HSV, HSV-HDAC1, or HSV-HDAC1 H141A catalytically dead mutant into the striatum, which resulted in robust neuronal expression of constructs ( Figure 6D ). After 24 hr, rats were subjected to bilateral transient forebrain ischemia. Six days later, brain sections were stained with gH2AX and fluoro-jade to label degenerating neurons. We and other groups have observed that fluoro-jade labels regions undergoing apoptotic neuronal death ( Figure S8 ) (Zuch et al., 2000) .
HSV-mediated overexpression of HDAC1 in the striatum resulted in a 38% reduction in gH2AX-positive neurons in the striatum compared to blank HSV, while the HDAC1 H141A mutant did not confer neuroprotection ( Figures 6E and 6F ). In addition, the number of degenerating neurons as labeled by fluoro-jade decreased significantly (33%) following HDAC1 expression (Figures 6E and 6G) . Importantly, this demonstrates that increasing HDAC1 activity can protect neurons against ischemia-induced DNA damage and neurotoxicity in vivo.
DISCUSSION
The CK-p25 mouse is a model for neurodegeneration in which neurons predictably begin to die at around 5-6 weeks of induction (Cruz et al., 2003; Fischer et al., 2005 ). In our current study, using an unbiased approach of examining the gene expression profile at a specific time point of induction followed by validation, we determined that aberrant expression of cell-cycle proteins and induction of double-strand DNA breaks are early events in p25-mediated neurodegeneration. Furthermore, we identified deregulation of HDAC1 activity as a mechanism involved in p25-mediated double-strand DNA break formation, cell-cycle protein expression, and neuronal death. Collectively, our results outline a pathway in neurodegeneration by which the inactivation of HDAC1 by p25 leads to enhanced susceptibility of DNA to double-strand breaks and the derepression of transcription, leading to aberrant expression of cell-cycle-related genes. In addition, our findings provide mechanistic insights into a common link between DNA damage and aberrant cell-cycle activity in neurodegeneration. As cell-cycle activity, DNA damage, and p25 accumulation are emerging as important pathological components of various neurodegenerative conditions, this pathway may constitute a shared mechanism responsible for neuronal death in multiple conditions such as stroke/ischemia, AD, and Parkinson's disease (PD). The neurotoxic effects of p25 accumulation and downstream events appear to be reversible ( Figure 3C ), further advocating the therapeutic potential of targeting this pathway in conditions involving neuronal death. Our proposed pathway is summarized in Figure 7 . It will be of interest to examine the protective properties of HDAC1 gain of function in various mouse models of neurodegenerative diseases such as amyotrophic lateral sclerosis, AD, and PD in future studies.
HDAC1 Inactivation by p25/Cdk5
We have demonstrated that p25 can inhibit multiple aspects of HDAC1 activity, including HDAC1 catalytic activity and association of HDAC1 with chromatin. This inhibition appears to be Cdk5 dependent ( Figure 4E ). How does p25/Cdk5 inhibit HDAC1? This may involve the posttranslational modification of HDAC1 by p25/ Cdk5. HDAC1 catalytic activity and association with corepressors can be modulated by phosphorylation (Galasinski et al., 2002; Pflum et al., 2001) . Alternatively, the p25/HDAC1 interaction may recruit p25/Cdk5 to HDAC1-containing corepressor complexes, where p25/Cdk5 phosphorylates and modulates corepressors required for HDAC1 activity, such as mSin3a or SMRT/NcoR2 (de Ruijter et al., 2003; Nagy et al., 1997) .
HDAC1 Inactivation and Cell-Cycle Activity
While aberrant cell-cycle activity in neurons in neurodegenerative states has been extensively documented, the underlying mechanisms and purposes are unclear. Our model introduces loss of HDAC1 activity as an underlying mechanism and suggests a simplified model of aberrant cell-cycle activity as a pathological derepression of multiple cell-cycle genes that are normally suppressed in neurons. p25/Cdk5 inhibited the transcriptional repression activity of HDAC1 in a luciferase reporter system ( Figure 4E ) and induced the disassociation of HDAC1 from the promoter region of the cell-cycle proteins E2F1 and p21/WAF ( Figure 4G ). Inhibition of HDAC1 in primary neurons resulted in upregulation of the cell-cycle activity marker Ki-67 ( Figure 5B) . Thus, our model suggests that constitutive HDAC1, which is normally associated with and represses cell-cycle-related genes Neuron Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity Figure 6 . HDAC1 Gain of Function Rescues against p25-Mediated Double-Strand DNA Breaks and Neurotoxicity (A) Overexpression of HDAC1 rescues against p25-mediated formation of gH2AX. Primary cortical neurons were transfected with vector, HDAC1, or HDAC2 as described. At 12 hr posttransfection, neurons were infected with p25-HSV virus, fixed after 8 hr, and immunostained for gH2AX. HDAC-positive cells were scored for immunoreactivity toward gH2AX. Scale bar = 50 mm. (B) Overexpression of HDAC1 rescues against p25-mediated neurotoxicity. Primary cortical neurons were transfected with p25-GFP plus blank vector, FLAG-HDAC1, or catalytically dead FLAG-HDAC1 H141A mutant. At 24 hr posttransfection, cells were fixed and immunostained for FLAG. p25-transfected cells and p25/HDAC1-transfected cells were scored for cell death based on nuclear condensation and neuritic integrity as described. For (A) and (B), averages from multiple experiments ± SD are shown. Representative micrographs for HDAC1 are shown in the left panels. Arrows indicate p25-positive neurons expressing or not expressing HDAC1. p values (**p < 0.005 for HDAC1 versus control) were calculated from multiple experiments by two-tailed, unpaired Student's t test. (C) Adult Sprague-Dawley rats were subjected to unilateral middle cerebral artery occlusion (MCAO) as described. Paraffin sections from brains fixed at 3 hr post MCAO show gH2AX immunoreactivity specifically within the ischemic area (left panels), but not in the contralateral area (right panels). Images are representative of multiple animals. Average numbers of gH2AX-positive cells per field (field diameter 900 mm) from multiple experiments ± SD are displayed. Twenty fields were counted per experiment. p values (**p < 0.005) were calculated from multiple experiments by two-tailed, unpaired Student's t test. Scale bar = 50 mm. (D) Injection of blank vector expressing GFP into striatum results in efficient and widespread expression in striatal neurons. Injection of virus into the striatum of adult Sprague-Dawley rats was followed by examination of GFP expression after 24 hr. Scale bar = 100 mm in left panel, 30 mm in right panel. (E) HDAC1 expression protects against ischemia-induced neuronal death and gH2AX formation in vivo. Adult Sprague-Dawley rats were injected with virus in the striatum, subjected to bilateral transient forebrain ischemia after 24 hr, and examined 6 days later for fluoro-jade and gH2AX staining as described. Representative images from mice injected with HSV-HDAC1, HSV-HDAC1 H141A, and blank HSV (vector) are shown. Scale bars = 100 mm. 
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Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity in postmitotic neurons, is inactivated by p25, leading to aberrant expression of cell-cycle genes. The idea that aberrant cell-cycle gene expression in neurons is a consequence of loss of HDAC1 repressional activity is consistent with the previously reported roles of HDAC1 as a transcriptional repressor for many cell-cycle genes. DNA damage induced by HDAC1 inactivation may also play a role in aberrant cell-cycle activity, as it has been demonstrated that increased oxidative DNA damage in the ''harlequin'' mouse mutants or drug-induced DNA damage in primary neurons can induce aberrant cell-cycle activity (Klein et al., 2002; Kruman et al., 2004) .
HDAC1 Inactivation and DNA Damage
Double-strand DNA breaks also preceded neuronal death in our p25 model. Future studies should address specifically how HDAC1 inactivation results in double-strand DNA damage and cell-cycle activity. One likely scenario involves hypersensitization of chromatin to DNA-damaging agents following loss of HDAC1 activity. In cancer cells, HDAC inhibitors can hypersensitize DNA to damaging agents such as ultraviolet and g irradiation by increasing the acetylation state and thus the accessibility of chromatin (Cerna et al., 2006) . Interestingly, overexpression of p25 or HDAC1 inhibition/ knockdown was sufficient to induce DNA damage in neurons and did not require additional genotoxic stimuli. Neurons are constantly subjected to DNA-damaging events; for example, it has been estimated that the typical neuron of an aged mouse is subjected to 2 million oxidative lesions per day (Hamilton et al., 2001) . Therefore, enhanced accessibility to DNA-damaging agents, combined with the relatively low levels of DNA repair factors present in neurons compared to proliferating cells (Gobbel et al., 1998; Nouspikel and Hanawalt, 2003) , may result in a robust accumulation of DNA damage.
DNA Damage, Cell-Cycle Activity, and Cell Death In this study, we report the formation of double-strand DNA breaks in the CK-p25 model as well as in a rodent model for stroke/ischemia. Both double-strand DNA breaks and cell-cycle activity preceded and were later tightly associated with neurodegeneration ( Figure 3B ). Compared to single-nucleotide lesions such as 8-oxoguanine lesions, double-strand DNA breaks are potentially lethal lesions that induce cell-cycle-dependent checkpoint responses in proliferating cells, resulting in cell death (Sancar et al., 2004) . However, because neurons are postmitotic, DNA damage events per se may have only limited toxic consequences, with the exception of altered gene expression (Nouspikel and Hanawalt, 2003) . Thus, double-strand DNA breaks and cell-cycle events such as DNA replication may synergistically induce cell death in CK-p25 neurons, likely in a checkpointdependent manner. In support of this notion, the p53 DNA damage checkpoint protein is upregulated in CK-p25 mice, and knockdown of p53 results in reduction of neuronal death in p25-transfected neurons (Kim et al., 2007) .
Role for HDAC1 in Postmitotic Neurons
As an important modulator of transcription, HDAC1 is undoubtedly involved in a variety of biological processes, and its involvement is well established in the regulation of the cell cycle in proliferating cells. Studies in the developing zebrafish retina demonstrate a role for HDAC1 in cell-cycle exit and differentiation of retinal progenitors into neurons (Yamaguchi et al., 2005) . Our study implicates HDAC1 in the maintenance and survival of adult neurons as well. Our findings suggest a function for HDAC1 in maintaining a state of ''quiescence'' through transcriptional repression of cell-cycle genes. We also demonstrate a role for HDAC1 in maintaining DNA integrity in adult neurons, a function that may be tightly linked to its regulation of the accessibility of DNA to damaging agents. Collectively, our results outline an important role within the CNS for HDAC1, the deregulation of which can lead to aberrant expression of cell-cycle genes, DNA damage, and ultimately death in adult neurons. Proposed model for p25-mediated cell death involving inhibition of HDAC1 activity, which leads to double-strand DNA breaks and aberrant cell-cycle activity. Neurotoxic stimuli such as ischemia result in p25 accumulation. This accumulation results in interaction with and inhibition of multiple aspects of HDAC1 activity, as shown in Figure 4 , in a manner that is dependent on Cdk5, as shown in Figure 4E . Inhibition of HDAC1 results in DNA damage and aberrant expression of cell-cycle genes, which is likely associated with local histone deacetylation ( Figure 4G ; Figure 5 ; Figure S7 ) and which ultimately leads to neuronal death (Figure 3) . The neurotoxic effects of p25 accumulation and downstream effects appear to be reversible before a certain period of induction ( Figure 3C ). Circles labeled ''N'' represents nucleosomes; ''A'' represents acetylation of histone tails. The nucleosomes with ''A'' represent acetylated nucleosomes and open chromatin loci, while the nucleosome at the far right represents a deacetylated nucleosome and closed chromatin locus.
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Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity Therapeutic Potential for HDAC1 Gain of Function We have shown that inhibition of HDAC1 can lead to DNA damage, cell-cycle gene expression, and neuronal death. In support of this idea, recent studies reporting the neuroprotective function of p130 and histone deacetylase-related protein (HDRP) have demonstrated a requirement for association with HDAC1 for these proteins' prosurvival effects (Liu et al., 2005; Morrison et al., 2006) . Furthermore, a recent phase I clinical trial of MS-275 in leukemia patients demonstrated neurologic toxicity manifesting as unsteady gait and somnolence as a dose-limiting toxicity (DLT) (Gojo et al., 2006) . In addition, numerous studies have demonstrated neurotoxic effects of high-dose general HDAC inhibitor treatment (Boutillier et al., 2002 (Boutillier et al., , 2003 Kim et al., 2004; Salminen et al., 1998) .
On the other hand, it is clear that HDAC inhibitors can have beneficial effects. We recently demonstrated that treatment with the nonselective HDAC inhibitor sodium butyrate enhances synapse formation and long-term memory recall , and learning and memory benefits have been reported with trichostatin A (Levenson et al., 2004; Vecsey et al., 2007) . Along similar lines, studies have shown beneficial effects of HDAC inhibitors in patients or models of psychiatric disorders such as depression (Citrome, 2003; Tsankova et al., 2006) . In addition, HDAC inhibitors such as phenylbutyrate have neuroprotective properties, within a therapeutic window, in models of Huntington's disease (HD) (Hockly et al., 2003; Langley et al., 2005; McCampbell et al., 2001; Steffan et al., 2001) . The use of HDAC inhibitors in HD models is based on the finding that huntingtin inhibits the HATs CREB-binding protein (CBP) and p300/CBP-associated factor (P/CAF), leading to a deficiency in levels of histone acetylation (Bates, 2001) .
Thus, both beneficial and adverse signals can be triggered by histone deacetylase inhibition. These effects are likely based on discrepancy in functions and gene targets of the different HDACs. For example, it was recently shown that specific downregulation of the class II HDACs HDAC4 and HDAC5 by the antidepressant imipramine derepresses BDNF expression and suppresses depression-like behavior (Tsankova et al., 2006) . Thus, inhibition of other HDACs may result in benefits through derepression of beneficial gene expression, while HDAC1 inhibition elicits deleterious consequences such as derepression of cell-cycle genes. We are currently in the process of elucidating the discrepancies in function and gene targets of the different HDACs that may account for the varying effects of HDAC inhibition.
Also, we cannot overlook the possibility that the beneficial versus deleterious effects of HDAC inhibition may also depend closely on the dosage and length of HDAC inhibition, as well as the context (e.g., state of hypoacetylation in Huntington's disease).
Our current study demonstrates the therapeutic potential for replenishing HDAC1 activity in certain neurodegenerative contexts such as ischemia (Figure 6 ). Previous studies with general HDAC inhibitors and our current study collectively illustrate the complex and broadly impacting nature of manipulating HDAC activity and underline the importance of chromatin regulation in a variety of processes in the CNS. Importantly, our study exemplifies the catastrophic consequences of deregulating this process and introduces an unexpected avenue for therapeutic strategies in neurodegeneration.
EXPERIMENTAL PROCEDURES
A detailed description of all procedures is included in the Supplemental Experimental Procedures.
Mice CK-p25 double-transgenic mice were raised on a doxycycline-containing diet and then switched to a normal diet at 6-8 weeks of age to induce p25-GFP in a postnatal, forebrain neuron-specific manner as described previously (Cruz et al., 2003) . Further details are provided in Supplemental Experimental Procedures.
Microarray Analyses
Total RNA was extracted from forebrains of 2-week-induced CK-p25 transgenic mice (n = 3) and uninduced CK-p25 controls (n = 3) using TRIzol reagent (Sigma). RNA was subjected to further purification with RNeasy columns (QIAGEN), reverse transcribed, biotin labeled, and hybridized onto Mouse Genome 430A 2.0 arrays (Affymetrix). Array data was analyzed using dCHIP and GeneChip Operating Software (GCOS, Affymetrix) as described in Supplemental Experimental Procedures.
Quantitative RT-PCR Analyses
Hippocampi from 2-week-induced CK-p25 mice and WT controls were incubated in RNAlater solution (Ambion). Total RNA was isolated using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Reverse transcription of equal amounts of total RNA was carried out using a SuperScript III First-Strand Synthesis kit (Invitrogen) according to the manufacturer's instructions. Semiquantitative conditions were obtained for all primers with sequence and cycle information provided in Supplemental Experimental Procedures. Band quantifications were normalized to those obtained for actin for each animal.
Comet Assay
Primary rat cortical neurons at 6-8 days in vitro (DIV) were infected with herpesvirus expressing p25 (p25-HSV) or lacZ (lacZ-HSV). After 10 hr, neurons were dissociated and embedded in a thin layer of agarose. Lysis, alkaline treatment, and single-cell gel electrophoresis (comet assay) were carried out.
Immunohistochemistry
Mice were transcardially perfused, and brains were prepared as paraffin sections or free-floating vibratome sections. Citrate buffer-based antigen retrieval was required for paraffin sections. Primary antibodies used with paraffin sections were gH2AX (monoclonal from Upstate, polyclonal from Trevigen), Ki-67 (Novocastra), PCNA (Oncogene Sciences), phosphoserine 10 histone H3 (Upstate), and GFP (monoclonal from Santa Cruz, polyclonal from Molecular Probes). Primary antibodies used with vibratome sections were GFP (Aves Labs), gH2AX (Upstate), cleaved caspase-3 (Asp175, Cell Signaling Technology), cleaved PARP1 (p25, Upstate), and NeuN (Chemicon). While the CA1 region of hippocampus is primarily shown in figures, similar results were observed in the cortex as well (data not shown).
Immunoblot Analyses CK-p25 and control forebrains were dissected and Dounce homogenized in RIPA buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease and phosphatase inhibitors. Equal quantities of brain lysates were subjected to SDS-PAGE and western blot analysis using antibodies to gH2AX (Trevigen), a-tubulin (Sigma), E2F1 (Santa Cruz), cyclin A (Santa Cruz), p35 (Santa Cruz), p27 (Santa Cruz), GFAP (Sigma), and bIII-tubulin (Sigma).
Luciferase Assays
HeLa cells were transfected with reporter, HDAC1-Gal4 fusion protein, and either blank vector or p25 plus Cdk5 expression vectors. At 15 hr posttransfection, cells were lysed with passive lysis buffer and luciferase assay was performed according to the manufacturer's instructions (Promega). Values were normalized to Gal4 protein levels, as renilla reporters were also substantially repressed by HDAC1-Gal4.
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Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity Coimmunoprecipitation Analyses HEK293T cells were transfected, lysed, subjected to immunoprecipitation with anti-FLAG-conjugated beads (Sigma), and analyzed by SDS-PAGE as described in Supplemental Experimental Procedures. For in vivo analysis of p25/HDAC1 interaction, 2-week-induced CK-p25 mice and WT control forebrains were Dounce homogenized in RIPA buffer, subjected to immunoprecipitation with anti-HDAC1 (Abcam), and analyzed as described in Supplemental Experimental Procedures. Antibodies to HDAC1 (Abcam), GFP (Santa Cruz), FLAG (Sigma), and p35/p25 (Sigma) were used for immunoblotting.
HDAC1 Enzymatic Activity Assay
HEK293T cells were transfected with blank vector or with p25 and Cdk5 expression vectors with Lipofectamine 2000. Cells were lysed with IP buffer at 15 hr posttransfection and immunoprecipitated with anti-HDAC1 (Abcam). Endogenous HDAC1 bound to beads was analyzed for histone deacetylase activity using a histone deacetylase assay kit (Upstate) according to the manufacturer's instructions. Histone deacetylase activity was normalized to input HDAC1 protein levels, which were analyzed by western blot. For analyses of HDAC1 activity in vivo, hippocampi were dissected from 2-week-induced CK-p25 mice and WT littermates and Dounce homogenized in IP buffer with high salt (400 mM NaCl) to aid HDAC1 extraction. Lysates were immunoprecipitated (in IP buffer with final 200 mM NaCl) and analyzed as described.
p25-and HDAC1-Based Toxicity Assays in Primary Neurons
Optimization of transfection conditions was required to minimize toxicity and gH2AX induced by the transfection procedure itself, as described in Supplemental Experimental Procedures. For cell death rescue assays, primary mouse cortical neurons were transfected with p25-GFP plus blank vector or p25-GFP plus FLAG-HDAC1. At 24 hr posttransfection, neurons were fixed and stained, and transfected neurons were scored for cell death based on nuclear morphology and neuritic integrity or scored for immunoreactivity toward cleaved caspase-3 (Cell Signaling Technology) in a blind manner. Only cells with a level of transfection sufficient for the entire neuritic outline to be clearly visible were counted. For gH2AX rescue assays, primary rat cortical neurons were transfected with FLAG-HDAC1, FLAG-HDAC2, or GFP and were infected with p25-HSV at 12 hr posttransfection. FLAG-HDAC1-, FLAG-HDAC2-, or GFP-positive neurons were blindly scored for gH2AX immunoreactivity.
Transient Forebrain Ischemia
For experiments examining HDAC1-mediated rescue of transient forebrain ischemia, rats were subjected to bilateral transient forebrain ischemia as described in Supplemental Experimental Procedures. Briefly, virus particles were injected into the striatum of adult Sprague-Dawley rats. After 24 hr, rats were subjected to ischemia by bilaterally occluding common carotid arteries with aneurysm clips for 15 min, after which cerebral blood flow was restored. After 6 days, mice were processed, subjected to gH2AX immunohistochemistry, and subjected to fluoro-jade staining as described previously (Wang et al., 2003) . Histological quantification of gH2AX immunoreactivity and fluoro-jade labeling in striatal neurons was carried out as described in Supplemental Experimental Procedures. Averaged neuronal cell counts were obtained from six animals per group.
For colabeling of fluoro-jade B with apoptosis markers, mice were subjected to transient forebrain ischemia by middle cerebral artery occlusion as described, except unilaterally with the contralateral hemisphere used as negative control. Cleaved caspase-3 (Cell Signaling Technology) and cleaved PARP1 (Upstate) were used as apoptotic markers.
Subcellular Fractionation
Rat primary neurons at DIV 5-7 were infected with GFP-HSV or p25-GFP-HSV. After 20 hr, neurons were subjected to chromatin fractionation as described in Supplemental Experimental Procedures. Cytosolic/nuclear fractionation was carried out using a nuclear extract kit (Active Motif) according to the manufacturer's instructions. Antibodies to GFP (Sigma), HDAC1 (Abcam), and neurofilament heavy subunit (Covance) were used for immunoblotting.
Chromatin Immunoprecipitation
For chromatin immunoprecipitation experiments, 293T cells were transfected with the indicated constructs, fixed 14 hr after transfection with 1% formaldehyde, and processed according to the manufacturer's instructions (#17-195, Upstate). HDAC1 (ChIP grade, Abcam) and acetyl-H3K9 (Upstate) antibodies were used to immunoprecipitate endogenous HDAC1 or histone H3 acetylated at lysine 9, respectively. Core promoter regions of p21 and E2F1 were amplified by PCR under semiquantitative conditions as described in the Supplemental Experimental Procedures.
Fear Conditioning
Fear conditioning experiments were carried out as described previously (Kim et al., 2007 ) using a fear conditioning apparatus (TSE Systems).
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